Gayatri BioOrganics Ltd

For the second consecutive session, Gayatri BioOrganics Ltd has extended its decline, hitting a fresh 52-week low of Rs 6.25 on 23 Jul 2026. This latest drop comes amid a broader underperformance relative to its sector and the wider market, signalling persistent selling pressure on the micro-cap commodity chemicals stock.

Despite a broadly positive market environment, Gayatri BioOrganics Ltd has plunged to a fresh 52-week low of Rs 6.49 on 22 Jul 2026, marking a 23.26% decline over the past year and underperforming the Sensex by a wide margin.

Gayatri BioOrganics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 22 July 2026, providing investors with the latest insights into the company’s performance and outlook.

Despite a broadly positive market environment, Gayatri BioOrganics Ltd has plunged to a fresh 52-week low of Rs 6.57 on 21 Jul 2026, marking a 67.5% decline from its 52-week high of Rs 20.25. This stark underperformance contrasts sharply with the Sensex, which, despite a minor dip, remains well above its 50-day moving average.

For the fourth consecutive session, Gayatri BioOrganics Ltd has seen its share price decline, culminating in a fresh 52-week low of Rs 6.86 on 15 Jul 2026. This marks a significant 66.1% drop from its 52-week high of Rs 20.25, underscoring persistent selling pressure despite a broadly positive market backdrop.

Gayatri BioOrganics Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 01 June 2026, reflecting a shift from the previous 'Sell' grade. However, the analysis and financial metrics presented here are based on the company’s current position as of 10 July 2026, providing investors with the latest insights into the stock’s performance and outlook.

Gayatri BioOrganics Ltd’s share price declined to a fresh 52-week low of ₹6.87 on 6 July 2026, marking a significant milestone in the stock’s ongoing downward trajectory. This new low comes after a sustained period of losses, reflecting persistent pressures on the company’s financial and market performance.

Gayatri BioOrganics Ltd’s stock price declined to a fresh 52-week low of Rs.7.03 on 2 July 2026, marking a significant downturn amid broader market gains. The stock has underperformed its sector and benchmark indices, reflecting ongoing concerns about the company’s financial health and valuation metrics.

For the second consecutive session, Gayatri BioOrganics Ltd has seen its share price decline, hitting a fresh 52-week low of Rs 7.2 on 1 Jul 2026. This drop comes despite the broader market's modest gains, underscoring stock-specific pressures weighing on the micro-cap commodity chemicals firm.

Gayatri BioOrganics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 29 June 2026, providing investors with the latest insights into its performance and outlook.

Gayatri BioOrganics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 17 June 2026, providing investors with the latest insights into the company’s performance and outlook.

Gayatri BioOrganics Ltd, a micro-cap player in the commodity chemicals sector, has seen its investment rating downgraded from Sell to Strong Sell as of 1 June 2026. This revision reflects a combination of deteriorating technical indicators, stagnant financial performance, weak valuation metrics, and poor quality fundamentals, signalling heightened risk for investors.

Gayatri BioOrganics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Gayatri BioOrganics Limited, a micro-cap commodity chemicals company with a market capitalisation of ₹117.00 crores, reported a quarterly loss of ₹0.42 crores for Q4 FY26 (Mar'26), marking a significant deterioration from the ₹0.17 crore loss recorded in Q4 FY25. The company's shares have tumbled 4.99% following the results announcement, trading at ₹14.08 as investor sentiment remains deeply negative towards this structurally challenged enterprise that has generated zero revenue for seven consecutive quarters.

Gayatri BioOrganics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 May 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook.

Surging from a 52-week low of Rs 6.13 to a fresh high of Rs 20, Gayatri BioOrganics Ltd has delivered an impressive 182.45% return over the past year, significantly outperforming the Sensex which declined by 4.09% during the same period. This milestone reflects a powerful technical momentum that has propelled the stock well above its key moving averages.